• Consumer Protection and Safety

• 28.

Alliance for A Stronger FDA Inc

About the Alliance TheAlliance for a Stronger FDA created in 2007 is a multistakeholder organization with 150 members devoted to advocating for sufficient appropriations for the FDA and educating policymakers and the public about the FDAs mission and responsibilities.

• Science, General (includes Interdisciplinary Scientific Activities)

• 29.

The Solution Lab Inc

PROVIDES HANDS-ON AND OTHER EDUCATIONAL AND TRAINING OPPORTUNITIES FOR SCIENCE-, TECHNOLOGY-, CLINICAL-, AND BUSINESS-ORIENTED STUDENTS, RECENT GRADUATES, AND SCIENTISTS FOR CAREERS IN INDUSTRY AND ENTREPRENEURSHIP, WITH A FOCUS ON LIFE-SCIENCE, HEALTHCARE, AND OTHER SCIENCE, TECHNOLOGY, ENGINEERING, OR MATHEMATICS ("STEM")-RELATED BUSINESSES.

• Biomedicine, Bioengineering

• 30.

Bioadvance

BIOADVANCE WAS ESTABLISHED IN 2001 AS ONE OF THREE LIFE SCIENCES GREENHOUSES FUNDED WITH A SHARE OF PENNSYLVANIA'S NATIONAL TOBACCO SETTLEMENT REVENUES, TO PROMOTE HUMAN HEALTH BY SUPPORTING BIOMEDICAL INNOVATION IN THE SOUTHEASTERN PA REGION.

• Business and Industry

• 31.

Bionorthtexas Inc

Changing lives through the convergence of #science and industry.

• Professional Societies & Associations

• 32.

Bionorthtexas Foundation

Changing lives through the convergence of #science and industry.

• Other Medical Research N.E.C.

• 33.

NP2

NP2 is disrupting the Pharma industry by putting people ahead of profits, selling life-saving generic drugs.

• Research Institutes and/or Public Policy Analysis

• 34.

GLOBAL ACTION TO END SMOKING

We are accelerating science-based efforts worldwide to end the smoking epidemic, with a focus on marginalized communities & low- & middle-income countries.

Arizona Bioindustry Association Inc

Seeking to unify, empower & advance our members, & make Arizona a place where bio companies can thrive AZBio is committed to building a top-ten life science industry in Arizona.

• Promotion of Business (Chambers of Commerce)

• 36.

THE BIOSIMILARS FORUM

Advancing biosimilars in the United States with the intent of expanding access and availability of biological medicines, and improving health care.